Zsolt Sebestyen

[Jurgen Kuball @JKuball]

Dennis Beringer with an excellent talk at #gdTLisbon2023 ⁦@forum_gd⁩ what a great meeting 😎

[Nature Biotechnology @NatureBiotech]

@Dream3DLab @IamAnneRios @prinsesmaximac @oncodeinstitute @TheCleversLab @JKuball @ZsoltSebestyen2 Mode-of-action of T-cell immunotherapies in focus #NBTintheNews https://t.co/Gy1ke64MDF https://t.co/XkzhBq0TDV

[Nature Biotechnology @NatureBiotech]

@Dream3DLab @IamAnneRios @prinsesmaximac @oncodeinstitute @TheCleversLab @JKuball @ZsoltSebestyen2 3D imaging reveals picture of T-cell activity to unlock solid tumor opportunity #NBTintheNews via @ScienceBoard https://t.co/iQsmUUFv1r

[Jurgen Kuball @JKuball]

Visualizing how TEGs, a next generation of engineered abTcells with high affinity g9d2TCR, efficiently interact and kill primary breast cancer organoids …. from “lazy bones” over “ticklers” to “hyper-engagers”. ⁦@Cancer_UMCU⁩ https://t.co/nw7ZU5S0xk

[Jurgen Kuball @JKuball]

56 miljoen euro Nationaal Groeifonds for @RegMed XB - great initiative to support cellular therapies or RM with an excellent link to cancer immune therapies at the UMC Utrecht #ATMP ⁦@ProgramUmc⁩ ⁦@IenI_UMCUtrecht⁩ https://t.co/6cxAVVKPkI

[Jurgen Kuball @JKuball]

Looking for an enthousiastic PhD students working on gdT cells and their receptors. Exciting science and stimulating environment :-) https://t.co/8SXBhSxddy